PSORIASIS Is ustekinumab superior to etanercept for psoriasis?

被引：6
|
作者：
Kuhn, Annegret [1 ]
Luger, Thomas A. [1 ]
机构：
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
来源：
NATURE REVIEWS RHEUMATOLOGY | 2010年 / 6卷 / 09期
关键词：
INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; TNF INHIBITION; TRIAL; EFFICACY; SAFETY;
D O I：
10.1038/nrrheum.2010.134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Both etanercept and ustekinumab have been shown to be strikingly effective in patients with psoriasis. A phase III trial comparing these two biologic agents for the treatment of moderate-to-severe psoriasis found that ustekinumab was superior to high-dose etanercept over a 12-week period; however, several questions remain to be addressed.
引用
收藏
页码：500 / 501
页数：3
相关论文
共 50 条
  • [41] Psoriasis Brodalumab vs Ustekinumab
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2016, 42 (03) : 73 - 73
  • [42] Ustekinumab for Psoriasis and Psoriatic Arthritis
    Gottlieb, Alice Bendix
    Goldminz, Ari Michael
    JOURNAL OF RHEUMATOLOGY, 2012, 39 : 86 - 89
  • [43] Flare of palmoplantar psoriasis with ustekinumab
    Daniel, Benjamin S.
    Baker, Chris
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (01) : 63 - 65
  • [44] Ustekinumab: differential use in psoriasis
    Uhlenhake, Elizabeth E.
    Mehregan, David A.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2011, 4 : 93 - 99
  • [45] Ustekinumab for the treatment of HIV psoriasis
    Paparizos, Vasileios
    Rallis, Efstathios
    Kirsten, Leuow
    Kyriakis, Kyriakos
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (06) : 398 - 399
  • [46] Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab
    van Muijen, Marloes E.
    Atalay, S.
    van Vugt, L. J.
    Vandermaesen, L. M. D.
    van den Reek, J. M. P. A.
    de Jong, E. M. G. J.
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 163 - 172
  • [47] Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis
    Ferrandiz, C.
    Garcia, A.
    Blasco, A. J.
    Lazaro, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (06) : 768 - 777
  • [48] Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice
    van der Schoot, L. S.
    Janssen, J. J.
    Bastiaens, M. T.
    de Boer-Brand, A.
    Christiaansen-Smit, C.
    Enomoto, D. N. H.
    Hovingh, R.
    Tupker, R. A.
    Seyger, M. M. B.
    Verhoef, L. M.
    van den Reek, J. M. P. A.
    de Jong, E. M. G. J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [49] Refractory psoriasis treatment with etanercept
    Santos, LM
    Martinez-Menchón, T
    Carazo, JLS
    Pérez-Ferriols, A
    Navarro, CJS
    Baixauli, JMF
    MEDICINA CLINICA, 2005, 125 (10): : 371 - 373
  • [50] Mechanisms of action of etanercept in psoriasis
    Tan, Jennifer K.
    Aphale, Abhishek
    Malaviya, Rama
    Sun, Yvonne
    Gottlieb, Alice B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2007, 12 (01) : 38 - 45
12345